Reduction in IV Associated Contamination
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01426217 |
|
Recruitment Status :
Completed
First Posted : August 31, 2011
Results First Posted : October 18, 2018
Last Update Posted : October 18, 2018
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Post-operative Infections | Device: Passive Bundle PSI (Problem Solving Innovations) Medical HubScrub, PSI Medical DocIt | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 594 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Investigator) |
| Primary Purpose: | Prevention |
| Official Title: | Reduction in Intraoperative Lumen Contamination of Standard 3-Way Open Lumen Stopcock Sets Through Use of a Novel, Passive Bundle |
| Study Start Date : | August 2011 |
| Actual Primary Completion Date : | November 2011 |
| Actual Study Completion Date : | November 2011 |
| Arm | Intervention/treatment |
|---|---|
|
No Intervention: Control
Control arm using standard of care operating room procedures and equipment
|
|
|
Experimental: Problem Solving Innovations (PSI) Experimental
Implementation of the passive bundle including HubScrub and DocIt
|
Device: Passive Bundle PSI (Problem Solving Innovations) Medical HubScrub, PSI Medical DocIt
Implementation of passive bundle which includes HubScrub and DocIt device into the operating room environment.
Other Names:
|
- Presence of Bacterial IV Stopcock Lumen Contamination [ Time Frame: 48 hours ]The presence of bacteria in the stopcock lumen was assessed by analyzing swab cultures of the lumens. Each swab potentially containing bacteria from any of the 3 lumens of the stopcock sets were analyzed
- Presence of Positive Bacterial Culture in IV Stopcock Due to Effluent Contamination [ Time Frame: Until positive, up to 5 days ]Open lumen ports were removed from the patient; sent directly to the anesthesiology microbiology laboratory; connected by the same clinical laboratory scientist to sterile catheters using sterile, aseptic technique; and injected directly into a BacT/Alert 3D system (bioMérieux Inc., Durham, NC) with 2 mL of sterile saline per port. BacT/Alert is a blood culture system that automatically monitors bacterial growth using colorimetry; a sensor inserted at the bottom of the bottle changes color on detecting the carbon dioxide produced by the growth of the bacteria. Catheters were then removed, and the bottles were directly incubated in the BacT/Alert system for 5 days or until positive. Once positive, the liquid in the bottle was examined to identify the organism.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Adult patient undergoing surgery or procedure in operating room
- Undergoing general anesthesia
Exclusion Criteria:
- Children (age < 18 years)
- Lack of intravenous access
- failure of anesthesia provider to complete training on experimental device
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01426217
| United States, New Hampshire | |
| Dartmouth-Hitchcock Medical Center | |
| Lebanon, New Hampshire, United States, 03756 | |
| Principal Investigator: | Bryan S Brindeiro, MD | Dartmouth-Hitchcock Medical Center | |
| Study Director: | Randy W Loftus, MD | Dartmouth-Hitchcock Medical Center |
Other Publications:
| Responsible Party: | Dartmouth-Hitchcock Medical Center |
| ClinicalTrials.gov Identifier: | NCT01426217 |
| Other Study ID Numbers: |
22743 |
| First Posted: | August 31, 2011 Key Record Dates |
| Results First Posted: | October 18, 2018 |
| Last Update Posted: | October 18, 2018 |
| Last Verified: | August 2018 |
|
IV contamination intravenous contamination stopcock contamination surgical site infection |
|
Infections |

